These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15358300)

  • 1. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold.
    Knight ZA; Chiang GG; Alaimo PJ; Kenski DM; Ho CB; Coan K; Abraham RT; Shokat KM
    Bioorg Med Chem; 2004 Sep; 12(17):4749-59. PubMed ID: 15358300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin.
    Domin J; Pages F; Volinia S; Rittenhouse SE; Zvelebil MJ; Stein RC; Waterfield MD
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):139-47. PubMed ID: 9337861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
    Northcott CA; Hayflick JS; Watts SW
    Hypertension; 2004 Apr; 43(4):885-90. PubMed ID: 14993194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PI3-kinase inhibitors LY294002 and wortmannin have different effects on proliferation of murine embryonic stem cells].
    Lianguzova MS; Chuĭkin IA; Nordheim A; Pospelov VA
    Tsitologiia; 2006; 48(7):560-8. PubMed ID: 17087147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
    Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
    EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.
    Galaria II; Nicholl SM; Roztocil E; Davies MG
    J Surg Res; 2005 Jul; 127(1):46-52. PubMed ID: 15964303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction.
    Yano H; Agatsuma T; Nakanishi S; Saitoh Y; Fukui Y; Nonomura Y; Matsuda Y
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):145-50. PubMed ID: 7492304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism.
    El-Kholy W; Macdonald PE; Lin JH; Wang J; Fox JM; Light PE; Wang Q; Tsushima RG; Wheeler MB
    FASEB J; 2003 Apr; 17(6):720-2. PubMed ID: 12586735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors of the PI3-kinase family.
    Knight ZA
    Curr Top Microbiol Immunol; 2010; 347():263-78. PubMed ID: 20473788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
    Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.
    Leverrier Y; Okkenhaug K; Sawyer C; Bilancio A; Vanhaesebroeck B; Ridley AJ
    J Biol Chem; 2003 Oct; 278(40):38437-42. PubMed ID: 12869549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1.
    Grey A; Chen Y; Paliwal I; Carlberg K; Insogna K
    Endocrinology; 2000 Jun; 141(6):2129-38. PubMed ID: 10830300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.
    Walker EH; Pacold ME; Perisic O; Stephens L; Hawkins PT; Wymann MP; Williams RL
    Mol Cell; 2000 Oct; 6(4):909-19. PubMed ID: 11090628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute regulation of the epithelial Na+ channel by phosphatidylinositide 3-OH kinase signaling in native collecting duct principal cells.
    Staruschenko A; Pochynyuk O; Vandewalle A; Bugaj V; Stockand JD
    J Am Soc Nephrol; 2007 Jun; 18(6):1652-61. PubMed ID: 17442787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110alpha inhibitors.
    Kendall JD; Rewcastle GW; Frederick R; Mawson C; Denny WA; Marshall ES; Baguley BC; Chaussade C; Jackson SP; Shepherd PR
    Bioorg Med Chem; 2007 Dec; 15(24):7677-87. PubMed ID: 17869522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases.
    Sue-A-Quan AK; Fialkow L; Vlahos CJ; Schelm JA; Grinstein S; Butler J; Downey GP
    J Cell Physiol; 1997 Jul; 172(1):94-108. PubMed ID: 9207930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and ligand-based design of mTOR and PI3-kinase inhibitors leading to the clinical candidates VS-5584 (SB2343) and SB2602.
    Poulsen A; Nagaraj H; Lee A; Blanchard S; Soh CK; Chen D; Wang H; Hart S; Goh KC; Dymock B; Williams M
    J Chem Inf Model; 2014 Nov; 54(11):3238-50. PubMed ID: 25317974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
    Kimmelman AC; Osada M; Chan AM
    Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 4-morpholino-pyrimidin-6-one and 4-morpholino-pyrimidin-2-one-containing Phosphoinositide 3-kinase (PI3K) p110β isoform inhibitors through structure-based fragment optimisation.
    Giordanetto F; Wållberg A; Cassel J; Ghosal S; Kossenjans M; Yuan ZQ; Wang X; Liang L
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6665-70. PubMed ID: 23010274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.